MARKETS LIVE
Loading markets…
Thursday, June 11, 2026 U.S. Edition

AbbVie Inc. ABBV

Loading live quote…
$224.77 -0.18 (-0.08%)
Price Chart
About AbbVie

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's…

Recent Quarters
QuarterRevenueNet IncomeEPS (dil.)Gross Margin
2026 Q1 $695.0M 0.39 71.9%
2025 Q4 $1.82B 1.02 72.6%
2025 Q3 $186.0M 0.10 66.4%
2025 Q2 $938.0M 0.52 71.8%